
Browsing restrictions can be lifted for a fee.
Zimmite Taiwan Ltd. engages in the industrial water treatment activities in Taiwan and China. It offers cooling water treatment agents, such as corrosion inhibitors, scale inhibitors, algaecides, biocides, rust removers, and cooling water all-in-one tablets; and boiler water treatment agents, including internal treatment additives, oxygen scavengers, neutralizing amines, and filming amines. The company also provides boiler fireside treatment additives comprising fuel oil additives and soot removers; and oil refinery and petrochemical process additives consisting of corrosion inhibitors, antifoulants, desalting agents, demulsifiersemulsion breakers, antifoamers/defoamers, metal passivating agents, polymerization inhibitors, and antioxidants. In addition, it offers wastewater treatment agents, including polymer flocculants, dewatering aids, heavy metal chelators, deodorants, and COD degradation agents; slow release tablets, such as cooling water treatment tablets, drain pan slime preventive tablets, and chlorine donors; and RO and scrubber chemicals. Further, the company provides technical services; water treatment technology supports; and oil mud dispersants, as well as sells water treatment raw materials. It primarily serves oil refineries and petrochemicals production plants, steel mills, power generation plants, office buildings, textile manufacturing processes, plastic manufacturing plants and processors, electronic manufacturing sector, and public facilities. Zimmite Taiwan Ltd. was founded in 1977 and is headquartered in New Taipei City, Taiwan.
8435
鉅邁
-1.87%
(-0.02)
The most recent financial report for 鉅邁 (8435) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 8435's short-term business performance and financial health. For the latest updates on 8435's earnings releases, visit this page regularly.
According to historical valuation range analysis, 鉅邁 (8435)'s current price-to-earnings (P/E) ratio is 11.16, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 鉅邁 (8435) reported an Operating Profit of 31.41M with an Operating Margin of 21.05% this period, representing a decline of 21.95% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 鉅邁 (8435) announced revenue of 149.22M, with a Year-Over-Year growth rate of -24.64%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 鉅邁 (8435) held Total Cash and Cash Equivalents of 130.95M, accounting for 0.15 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 鉅邁 (8435) achieved the “three margins increasing” benchmark, with a gross margin of 52.7%%, operating margin of 21.05%%, and net margin of 29.9%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 8435's profit trajectory and future growth potential.
According to the past four quarterly reports, 鉅邁 (8435)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.41. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
鉅邁 (8435)'s Free Cash Flow (FCF) for the period is -6.59M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 670.33% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.